A nonlinear mixed effects IVIVC model for multi-release drug delivery systems

Area of Science:

• Pharmaceutical Sciences
• Pharmacokinetics
• Drug Delivery Systems

Background:

• Developing in vitro-in vivo correlation (IVIVC) models is crucial for predicting in vivo drug performance from in vitro data.
• Dual-release formulations offer complex drug release profiles, requiring robust modeling techniques.
• Galantamine is a key therapeutic agent, necessitating precise characterization of its delivery systems.

Purpose of the Study:

• To develop and validate an in vitro-in vivo correlation (IVIVC) model for Galantamine dual-release formulations.
• To incorporate a convolution step, as described by O'Hara et al., into the IVIVC model.
• To characterize a dual-release system comprising both immediate and controlled release elements.

Main Methods:

• Development of a Level A IVIVC model.
• Application of a convolution step for data analysis.
• Utilizing four distinct Galantamine formulations for model testing.
• Validation of the model against FDA criteria for internal and external consistency.

Main Results:

• Successful development of a Level A IVIVC model for Galantamine.
• The model demonstrated robust predictive capability for the dual-release system.
• The developed IVIVC model met all internal and external validation criteria set by the FDA.

Conclusions:

• The developed IVIVC model is suitable for characterizing Galantamine dual-release formulations.
• This modeling approach can streamline drug product development and quality control.
• The validated IVIVC model supports regulatory compliance and enhances prediction of in vivo performance.